Dr. A. Dosanjh

San Diego School of Medicine, USA



Post-Doctoral Fellowships, Pulmonary Fellowship/ Advanced Lung Transplantation Fellowship- certified UNOS

M.D., University of California, San Diego School of Medicine

B.A., Brown University, Honors Biology and English Literature


  1. Dosanjh, A (PI), Teschmacher L, Yuh D and RC Robbins. Pleural Disease Among CF patients undergoing Lung Transplantation. Pediatric Transplantation 1998; 2(4):283-7.
  2. Dosanjh A (PI), Theodore J, and  D Pappagianis. Probable False positive Coccidioidomycosis serologic testing among CF Patients. Pediatric Transplantation 1998; 2(4), 313-7.
  3. Dosanjh A, Wan B, Morris RE. Pirfenidone: A Novel Anti-fibrotic agent with implications for the treatment of Obliterative Bronchiolitis Transplant Proceedings 1998; 30(5) :1910-1.
  4. Dosanjh  A (PI), Elashoff D, Robbins RC. Increased IL-8 and Elastase Activity in the BAL fluid of Lung Transplant Recipients J Interferon and Cytokine Research 1998; 18 (10): 851-4.
  5. Dosanjh A (PI), Beck, C and RC Robbins.  Perioperative Drug Reactions among CF lung Transplant Recipients. Pediatric Asthma , Allergy and Immunology   1998; vol 12.
  6. Palivizumab, A Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization from Respiratory Syncytial Virus Infection in High-risk Infants.IMpact RSV study: group: Co-I: Pediatrics 1998; 102(3) 531-537..
  7. Dosanjh AK (PI), Robinson TE, Strauss J, Berry G. Eosinophil activation in cardiac and pulmonary acute allograft rejection. J Heart Lung Transplant 1998; 17(10):1038
  8. Dosanjh (PI), Lakhani, Chin, Elashoff, Hsu, Hilman. A  Comparison of sinus and airway microbiologic cultures in cystic fibrosis patients with maxillary antrostomies. Pediatric Transplantation 2000; 4:182-85
  9. Dosanjh (PI), Morris and Wan. Bronchial epithelial cell- derived cytokine IL-10 and lung fibroblast proliferation. Transplantation Proceedings 2001; 33(102):352-4.
  10. Dosanjh (PI), Wan, Ikonen, Morris. Airway goblet cells and respiratory epithelial injury in an animal model of obliterative airways disease (OAD). Am J Transplant 2001; 4: 321-4.
  11. Dosanjh A (PI) Ikonen,  Wan, Morris. Pirfenidone: A novel anti-fibrotic agent and progressive chronic allograft rejection. Pulm Pharmacol Ther 2002; 15: 433-7
  12. Dosanjh A, Connective Tissue Growth Factor expression in human bronchial epithelial cells Acta Biochimica Biophys 2006
  13. Dosanjh  A. Transforming growth factor-beta expression induced by rhinovirus infection in respiratory epithelial cells.  Acta Biochimica Biophys Dec 2006
  14. Dosanjh A, Pirfenidone: review of its possible use in transplantation: Eur J Pharm, 2006
  15. Dosanjh A, Pirfenidone and chronic progressive obliterative airway disease. JHLT, 2006
  16. Dosanjh A.   The use of long-term  controller medications in asthmatic patients being discharged from the ED- why the controversy? Am J Emerg Med May 2007
  17. Dosanjh A. Pirfenidone: a novel potential therapeutic agent in the management of chronic allograft rejection. Transplant Proc Sept 2007
  18. Dosanjh A. Adenovirus and  Post-infectious Bronchiolitis Obliterans in Children. Current Pediatric Reviews 2007
  19. Dosanjh A. Pediatric Mediastinal Disease- Current Pediatric Reviews, 2008
  20. Dosanjh A. The inhibition of superoxide production by Cystic Fibrosis Soluble Phase. The Open Respiratory Journal, 2008
  21. Dosanjh A, Koziol J. A Comparison of CF and Non-CF school- age children undergoing lung transplantation.  Transpl Int 2009 (cited in the AJRCCM CF update 2009)
  22. Dosanjh A, Muchmore EA. Expression of DF508 CFTR decreases Membrane Sialylation. The Open Respiratory Journal, 2009
  23. Dosanjh A. Allergic Rhinitis and Sleep Disordered Breathing.  Allergol and Immunopathol, 2009
  24. Chan M, Sitaraman S, Dosanjh A. Asthma Control Test and Peak Expiratory Flow Rate: Two Independent Measures of Asthma Control, 2009